Octet Research Inc.
Share
High late stage clinical failure rate, long development time, and increasing cost are unsustainable hurdles facing pharma industry. A well designed drug development process with model based approach to get a quantitative understanding of the underlying physiology of health, disease, and body's response to drugs has a huge potential (unfortunately very underutilized so far) to help pharma companies
09/14/2016
Check out event http://ow.ly/LIum304dj4x and RSVP!
Exciting Speaker Lineup for Boston Quantitative & Systems Pharmacology We have built a small but growing voluntary community of researchers in academia and industry, interested in different areas of application of modeling and simulation (M&S) in drug development, called
07/08/2015
Click here to claim your Sponsored Listing.
Category
Website
Address
Boston, MA
